Month: September 2025

Bridge to Life Appoints David Castiglioni as Chief Commercial Officer to Head Global Commercial Operations and Lead the U.S. Commercialization of VitaSmart™

CHICAGO, Sept. 29, 2025 /PRNewswire/ -- Bridge to Life Ltd., a leader in organ preservation solutions and perfusion technology, today...

Medicus Pharma Ltd. Receives Positive Feedback From the Food and Drug Adminstration (FDA) Type C Meeting Supporting the Development of Skinject

The FDA agrees that the Company may follow 505(b)(2) regulatory pathway to non-invasively treat basal cell carcinoma (BCC) of the...

SeaStar Medical Reports Positive Early Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) at the 5th International Symposium on Acute Kidney Injury in Children

Data show results consistent with clinical trial experienceA high level of safety – no device-related adverse eventsStrong survival data extending...

error: Content is protected !!